Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …

Generic medicines have the same efficacy and safety as originators at lower prices;
however, there are concerns with their utilization in Nigeria. Objective was to evaluate …

The prescription of generic drugs represents one of the main cost-containment strategies of
health systems, aimed at reducing pharmaceutical expenditure. In this context, most …

Objective: Global expenditure on medicines is increasing driven by a number of factors.
These include the launch of new premium-priced medicines for complex diseases including …

Objective: Pharmaceutical companies spend significant amount of resources on promotion
influencing the prescribing behavior of physicians. Drug promotion can negatively impact on …

Introduction: There are concerns over the quality of generic medicines in Pakistan. This is
due to perceived non-compliance with good manufacturing practice (GMP), whereby the …

Background: Generic switching is a policy that has shown success in minimising
pharmaceutical costs. It has also been used to mitigate recurrent and sudden drug …

Getting the most out of the pharmaceutical budget is critical across all countries as the
financial pressures on healthcare systems intensify. In this paper, we review global practice …

The increasing use of lower-cost multiple sourced medicines (generics) and biosimilars are
essential to attain or retain universal healthcare in the face of continual pressure on …

Long-term administration of classic immunosuppressants can induce severe adverse effects.
The development of novel immunosuppressants confronts great challenges and …